Economic evaluation of cholinesterase inhibitor therapy for dementia: comparison of Alzheimer's disease and Dementia with Lewy bodies.
OBJECTIVE: To assess the cost effectiveness of cholinesterase inhibitor (ChEI) treatment in patients with Alzheimer's disease (AD) and Dementia with Lewy bodies (DLB). METHOD: We used 4-month open label follow-up data from routine memory clinic patients. There were 852 patients with AD and 112...
Auteurs principaux: | Gustavsson, A, Van Der Putt, R, Jönsson, L, Mcshane, R |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2009
|
Documents similaires
-
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
par: Rolinski, M, et autres
Publié: (2012) -
Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies.
par: Ballard, C, et autres
Publié: (2007) -
Cholinesterase inhibitor treatment increases phosphotau accumulation in Alzheimer's disease but reduces A beta in dementia with Lewy bodies
par: Chalmers, K, et autres
Publié: (2008) -
Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology.
par: McShane, R, et autres
Publié: (2001) -
Depression in dementia with Lewy bodies: A comparison with Alzheimer's disease.
par: Pai-Yi Chiu, et autres
Publié: (2017-01-01)